Diet and aging

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2012, Pages

  Ribarič, Samo ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; AGE-RELATED CHANGES; CALORIC RESTRICTION; CARDIO-VASCULAR DISEASE; CELL-TO-CELL SIGNALING; CHRONIC DISEASE; DNA METHYLATION; EPIGENETIC MECHANISMS; FOOD SUPPLEMENTS; HISTONE MODIFICATION; LIFE SPAN; MIMETICS; POLYPHENOLS; RESVERATROL; SIGNALING PATHWAYS; STRESS RESPONSE;

DNA SEQUENCES; NUTRITION;

DISEASES;

ADIPONECTIN; ANTINEOPLASTIC AGENT; DNA METHYLTRANSFERASE; GLUCOSE TRANSPORTER 4; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HISTONE DEMETHYLASE; HISTONE METHYLTRANSFERASE; MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA; RAPAMYCIN; RESVERATROL; RETINOIC ACID; SOMATOMEDIN C; TARGET OF RAPAMYCIN KINASE; TRANSCRIPTION FACTOR FOXO;

AGING; APOPTOSIS; ATHEROSCLEROSIS; AUTOPHAGY; CALORIC RESTRICTION; CANCER CHEMOTHERAPY; CYTOKINE RELEASE; DEACETYLATION; DIET; DIET RESTRICTION; DNA METHYLATION; ENERGY EXPENDITURE; EPIGENETICS; EXERCISE; GENE EXPRESSION; HEART RATE VARIABILITY; HISTONE ACETYLATION; HISTONE METHYLATION; HISTONE MODIFICATION; HUMAN; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LIFESPAN; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PROMYELOCYTIC LEUKEMIA; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; GENETIC EPIGENESIS; GENETICS; NUTRITIONAL STATUS; PHYSIOLOGY;

ANIMALIA;

AGING; ANIMALS; CALORIC RESTRICTION; DIET; EPIGENESIS, GENETIC; HUMANS; NUTRITIONAL STATUS;

EID: 84866153000     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2012/741468     Document Type: Review

References (288)

1. Mckay J. A., Mathers J. C., Diet induced epigenetic changes and their implications for health. Acta Physiologica 2011 202 2 103 118 2-s2.0-79955675256 10.1111/j.1748-1716.2011.02278.x
2. Diet, nutrition and the prevention of chronic diseases. World Health Organization Technical Report Series 2003 916 18 1 149
3. Barker D. J. P., Osmond C., Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. The Lancet 1986 1 8489 1077 1081 2-s2.0-0022621648 (Pubitemid 16106274)
4. Kensara O. A., Wootton S. A., Phillips D. I., Patel M., Jackson A. A., Elia M., Fetal programming of body composition: relation between birth weight and body composition measured with dual-energy X-ray absorptiometry and anthropometric methods in older Englishmen. The American Journal of Clinical Nutrition 2005 82 5 980 987 2-s2.0-32944472635 (Pubitemid 43779754)
5. Osmond C., Barker D. J. P., Winter P. D., Fall C. H. D., Simmonds S. J., Early growth and death from cardiovascular disease in women. British Medical Journal 1993 307 6918 1519 1524 2-s2.0-0027484614 (Pubitemid 23357224)
6. Hales C. N., Barker D. J. P., Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 1992 35 7 595 601 2-s2.0-0026772772 10.1007/BF00400248
7. Cooper C., Fall C., Egger P., Hobbs R., Eastell R., Barker D., Growth in infancy and bone mass in later life. Annals of the Rheumatic Diseases 1997 56 1 17 21 2-s2.0-0031020109 (Pubitemid 27060567)
8. Ozanne S. E., Hales C. N., Lifespan: catch-up growth and obesity in male mice. Nature 2004 427 6973 411 412 2-s2.0-0842328994 (Pubitemid 38168484)
9. Vehaskari V. M., Prenatal programming of kidney disease. Current Opinion in Pediatrics 2010 22 2 176 182 2-s2.0-77952264863 10.1097/MOP.0b013e328336ebc9
10. Gabory A., Attig L., Junien C., Sexual dimorphism in environmental epigenetic programming. Molecular and Cellular Endocrinology 2009 304 1-2 8 18 2-s2.0-67349190274 10.1016/j.mce.2009.02.015
11. Bird A., DNA methylation patterns and epigenetic memory. Genes & Development 2002 16 1 6 21 2-s2.0-0036144048 10.1101/gad.947102 (Pubitemid 34049633)
12. Wu H., Tao J., Sun Y. E., Regulation and function of mammalian DNA methylation patterns: a genomic perspective. Briefings in Functional Genomics 2012 11 3 240 250
13. Zou X., Ma W., Solov'yov I. A., Chipot C., Schulten K., Recognition of methylated DNA through methyl-CpG binding domain proteins. Nucleic Acids Research 2012 40 6 2747 2758
14. Crider K. S., Yang T. P., Berry R. J., Bailey L. B., Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate's role. Advances in Nutrition 2012 3 1 21 38
15. Rauch T. A., Zhong X., Wu X., Wang M., Kernstine K. H., Wang Z., Riggs A. D., Pfeifer G. P., High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer. Proceedings of the National Academy of Sciences of the United States of America 2008 105 1 252 257 2-s2.0-38349135680 10.1073/pnas.0710735105
16. Ehrlich M., DNA hypomethylation in cancer cells. Epigenomics 2009 1 239 259
17. Davis C. D., Uthus E. O., Finley J. W., Dietary selenium and arsenic affect DNA methylation in vitro in Caco-2 cells and in vivo in rat liver and colon. The Journal of Nutrition 2000 130 12 2903 2909 2-s2.0-0034533186 (Pubitemid 32005315)
18. Zeng H., Yan L., Cheng W. H., Uthus E. O., Dietary selenomethionine increases exon-specific DNA methylation of the p53 gene in rat liver and colon mucosa. The Journal of Nutrition 2011 141 8 1464 1468 2-s2.0-79961102553 10.3945/jn.111.140715
19. Van Straten E. M. E., Bloks V. W., Huijkman N. C. A., Baller J. F. W., Van Meer H., Lütjohann D., Kuipers F., Plösch T., The liver X-receptor gene promoter is hypermethylated in a mouse model of prenatal protein restriction. American Journal of Physiology 2010 298 2 R275 R282 2-s2.0-75449118269 10.1152/ajpregu.00413.2009
20. Bannister A. J., Kouzarides T., Regulation of chromatin by histone modifications. Cell Research 2011 21 3 381 395 2-s2.0-79952534189 10.1038/cr.2011.22
21. Link A., Balaguer F., Goel A., Cancer chemoprevention by dietary polyphenols: promising role for epigenetics. Biochemical Pharmacology 2010 80 12 1771 1792 2-s2.0-78049429911 10.1016/j.bcp.2010.06.036
22. Cheng X., Blumenthal R. M., Coordinated chromatin control: structural and functional linkage of DNA and histone methylation. Biochemistry 2010 49 14 2999 3008 2-s2.0-77950678085 10.1021/bi100213t
23. Tan Y., Zhang B., Wu T., Skogerbo G., Zhu X., Guo X., He S., Chen R., Transcriptional inhibiton of Hoxd4 expression by miRNA-10a in human breast cancer cells. BMC Molecular Biology 2009 10, article 12 2-s2.0-65549158866 10.1186/1471-2199-10-12
24. Hawkins P. G., Morris K. V., RNA and transcriptional modulation of gene expression. Cell Cycle 2008 7 5 602 607 2-s2.0-41849131453 (Pubitemid 351498998)
25. Bartel D. P., MicroRNAs: target recognition and regulatory functions. Cell 2009 136 2 215 233 2-s2.0-58249088751 10.1016/j.cell.2009.01.002
26. Kusenda B., Mraz M., Mayer J., Pospisilova S., MicroRNA biogenesis, functionality and cancer relevance. Biomedical papers of the Medical Faculty of the University Palack Olomouc, Czechoslovakia 2006 150 2 205 215 2-s2.0-41149098674
27. Bentwich I., Avniel A., Karov Y., Aharonov R., Gilad S., Barad O., Barzilai A., Einat P., Einav U., Meiri E., Sharon E., Spector Y., Bentwich Z., Identification of hundreds of conserved and nonconserved human microRNAs. Nature Genetics 2005 37 7 766 770 2-s2.0-22844440427 10.1038/ng1590 (Pubitemid 41754896)
28. Lewis B. P., Burge C. B., Bartel D. P., Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005 120 1 15 20 2-s2.0-11844278458 10.1016/j.cell.2004.12.035 (Pubitemid 40094598)
29. Friedman R. C., Farh K. K. H., Burge C. B., Bartel D. P., Most mammalian mRNAs are conserved targets of microRNAs. Genome Research 2009 19 1 92 105 2-s2.0-60149095444 10.1101/gr.082701.108
30. Lim L. P., Lau N. C., Weinstein E. G., Abdelhakim A., Yekta S., Rhoades M. W., Burge C. B., Bartel D. P., The microRNAs of Caenorhabditis elegans. Genes & Development 2003 17 8 991 1008 2-s2.0-0037447334 10.1101/gad.1074403 (Pubitemid 36459452)
31. Esquela-Kerscher A., Slack F. J., OncomirsmicroRNAs with a role in cancer. Nature Reviews Cancer 2006 6 4 259 269 2-s2.0-33645294070 10.1038/nrc1840
32. Mathers J. C., Strathdee G., Relton C. L., Induction of epigenetic alterations by dietary and other environmental factors. Advances in Genetics 2010 71 4 39 2-s2.0-77957333258 10.1016/B978-0-12-380864-6.00001-8
33. Milenkovic D., Deval C., Gouranton E., Modulation of miRNA expression by dietary polyphenols in apoE deficient mice: a new mechanism of the action of polyphenols. PLoS One 2012 7 1 e29837
34. Sun Q., Cong R., Yan H., Gu H., Zeng Y., Liu N., Chen J., Wang B., Genistein inhibits growth of human uveal melanoma cells and affects microRNA-27a and target gene expression. Oncology Reports 2009 22 3 563 567 2-s2.0-70349316774 10.3892/or00000472
35. Sun M., Estrov Z., Ji Y., Coombes K. R., Harris D. H., Kurzrock R., Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells. Molecular Cancer Therapeutics 2008 7 3 464 473 2-s2.0-41649090153 10.1158/1535-7163.MCT-07-2272 (Pubitemid 351482129)
36. Yang J., Cao Y., Sun J., Zhang Y., Curcumin reduces the expression of Bcl-2 by upregulating miR-15a and miR-16 in MCF-7 cells. Medical Oncology 2010 27 4 1114 1118 2-s2.0-79951767903 10.1007/s12032-009-9344-3
37. Careccia S., Mainardi S., Pelosi A., Gurtner A., Diverio D., Riccioni R., Testa U., Pelosi E., Piaggio G., Sacchi A., Lavorgna S., Lo-Coco F., Blandino G., Levrero M., Rizzo M. G., A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytes. Oncogene 2009 28 45 4034 4040 2-s2.0-70449628970 10.1038/onc.2009.255
38. Weiss F. U., Marques I. J., Woltering J. M., Vlecken D. H., Aghdassi A., Partecke L. I., Heidecke C. D., Lerch M. M., Bagowski C. P., Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer. Gastroenterology 2009 137 6 2136 2145 2-s2.0-70649104670 10.1053/j.gastro.2009.08.065
39. Davidson L. A., Wang N., Shah M. S., Lupton J. R., Ivanov I., Chapkin R. S., n-3 Polyunsaturated fatty acids modulate carcinogen-directed non-coding microRNA signatures in rat colon. Carcinogenesis 2009 30 12 2077 2084 2-s2.0-73949158230 10.1093/carcin/bgp245
40. Melkamu T., Zhang X., Tan J., Zeng Y., Kassie F., Alteration of microRNA expression in vinyl carbamate-induced mouse lung tumors and modulation by the chemopreventive agent indole-3-carbinol. Carcinogenesis 2010 31 2 252 258 2-s2.0-77649196575 10.1093/carcin/bgp208 bgp208
41. Marsit C. J., Eddy K., Kelsey K. T., MicroRNA responses to cellular stress. Cancer Research 2006 66 22 10843 10848 2-s2.0-33845312687 10.1158/0008-5472.CAN-06-1894 (Pubitemid 44876980)
42. Kutay H., Bai S., Datta J., Motiwala T., Pogribny I., Frankel W., Jacob S. T., Ghoshal K., Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. Journal of Cellular Biochemistry 2006 99 3 671 678 2-s2.0-33749479908 10.1002/jcb.20982 (Pubitemid 44521987)
43. Loewith R., Hall M. N., Target of rapamycin (TOR) in nutrient signaling and growth control. Genetics 2011 189 4 1177 1201
44. Laplante M., Sabatini D. M., mTOR signaling in growth control and disease. Cell 2012 149 2 274 293
45. Yen W. L., Klionsky D. J., How to live long and prosper: autophagy, mitochondria, and aging. Physiology 2008 23 5 248 262 2-s2.0-57049186623 10.1152/physiol.00013.2008
46. Pearce L. R., Komander D., Alessi D. R., The nuts and bolts of AGC protein kinases. Nature Reviews 2010 11 1 9 22 2-s2.0-72949093349 10.1038/nrm2822
47. Sancak Y., Thoreen C. C., Peterson T. R., Lindquist R. A., Kang S. A., Spooner E., Carr S. A., Sabatini D. M., PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Molecular Cell 2007 25 6 903 915 2-s2.0-33947264077 10.1016/j.molcel.2007.03.003 (Pubitemid 46436534)
48. Easley C. A. IV, Ben-Yehudah A., Redinger C. J., Oliver S. L., Varum S. T., Eisinger V. M., Carlisle D. L., Donovan P. J., Schatten G. P., MTOR-mediated activation of p70 S6K induces differentiation of pluripotent human embryonic stem cells. Cellular Reprogramming 2010 12 3 263 273 2-s2.0-77954945936 10.1089/cell.2010.0011
49. Julien L. A., Carriere A., Moreau J., Roux P. P., mTORC1-activated S6K1 phosphorylates rictor on threonine 1135 and regulates mTORC2 signaling. Molecular and Cellular Biology 2010 30 4 908 921 2-s2.0-75749105049 10.1128/MCB.00601-09
50. Choo A. Y., Yoon S. O., Kim S. G., Roux P. P., Blenis J., Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation. Proceedings of the National Academy of Sciences of the United States of America 2008 105 45 17414 17419 2-s2.0-56249147509 10.1073/pnas.0809136105
51. Zhang D., Contu R., Latronico M. V. G., Zhang J. L., Rizzi R., Catalucci D., Miyamoto S., Huang K., Ceci M., Gu Y., Dalton N. D., Peterson K. L., Guan K. L., Brown J. H., Chen J., Sonenberg N., Condorelli G., MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice. The Journal of Clinical Investigation 2010 120 8 2805 2816 2-s2.0-77955290360 10.1172/JCI43008
52. Dowling R. J. O., Topisirovic I., Alain T., Bidinosti M., Fonseca B. D., Petroulakis E., Wang X., Larsson O., Selvaraj A., Liu Y., Kozma S. C., Thomas G., Sonenberg N., mTORCI-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs. Science 2010 328 5982 1172 1176 2-s2.0-77952967459 10.1126/science.1187532
53. Foster K. G., Acosta-Jaquez H. A., Romeo Y., Ekim B., Soliman G. A., Carriere A., Roux P. P., Ballif B. A., Fingar D. C., Regulation of mTOR complex 1 (mTORC1) by raptor Ser863 and multisite phosphorylation. The Journal of Biological Chemistry 2010 285 1 80 94 2-s2.0-73649098283 10.1074/jbc.M109.029637
54. Kwak D., Choi S., Jeong H., Osmotic stress regulates mammalian target of rapamycin(mTOR) complex 1 via c-Jun N-terminal Kinase (JNK)-mediated Raptor protein phosphorylation. The Journal of Biological Chemistry 2012 287 22 18398 18407
55. Sato T., Nakashima A., Guo L., Tamanoi F., Specific activation of mTORC1 by Rheb G-protein in vitro involves enhanced recruitment of its substrate protein. The Journal of Biological Chemistry 2009 284 19 12783 12791 2-s2.0-67649823420 10.1074/jbc.M809207200
56. Gwinn D. M., Shackelford D. B., Egan D. F., Mihaylova M. M., Mery A., Vasquez D. S., Turk B. E., Shaw R. J., AMPK phosphorylation of raptor mediates a metabolic checkpoint. Molecular Cell 2008 30 2 214 226 2-s2.0-42949139481 10.1016/j.molcel.2008.03.003 (Pubitemid 351626684)
57. Magnuson B., Ekim B., Fingar D. C., Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks. The Biochemical Journal 2012 441 1 1 21
58. Melnik B. C., Excessive Leucine-mTORC1-signalling of cow milk-based infant formula: the missing link to understand early childhood obesity. Journal of Obesity 2012 2012 197653
59. DeHart A. K. A., Schnell J. D., Allen D. A., Tsai J. Y., Hicke L., Receptor internalization in yeast requires the Tor2-Rho1 signaling pathway. Molecular Biology of the Cell 2003 14 11 4676 4684 2-s2.0-0345255690 10.1091/mbc.E03-05-0323 (Pubitemid 37444665)
60. Powers T., Aronova S., Niles B., TORC2 and sphingolipid biosynthesis and signaling. lessons from budding yeast. The Enzymes 2010 27 177 197 2-s2.0-77954904218 10.1016/S1874-6047(10)27010-5
61. Zinzalla V., Stracka D., Oppliger W., Hall M. N., Activation of mTORC2 by association with the ribosome. Cell 2011 144 5 757 768 2-s2.0-79952293503 10.1016/j.cell.2011.02.014
62. Hagiwara A., Cornu M., Cybulski N., Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c. Cell Metabolism 2012 15 5 725 738
63. Cybulski N., Hall M. N., TOR complex 2: a signaling pathway of its own. Trends in Biochemical Sciences 2009 34 12 620 627 2-s2.0-70449900928 10.1016/j.tibs.2009.09.004
64. Sparks C. A., Guertin D. A., Targeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapy. Oncogene 2010 29 26 3733 3744 2-s2.0-77954235821 10.1038/onc.2010.139
65. Ikai N., Nakazawa N., Hayashi T., Yanagida M., The reverse, but coordinated, roles of Tor2 (TORC1) and Tor1 (TORC2) kinases for growth, cell cycle and separase-mediated mitosis in Schizosaccharomyces pombe. Open Biology 2011 1 10.1098/rsob.110007
66. Frias M. A., Thoreen C. C., Jaffe J. D., Schroder W., Sculley T., Carr S. A., Sabatini D. M., mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s. Current Biology 2006 16 18 1865 1870 2-s2.0-33748471980 10.1016/j.cub.2006.08.001 (Pubitemid 44354144)
67. McCay C. M., Crowell M. F., Maynard L. A., The effect of retarded growth upon the Length of life span and upon the ultimate body size. The Journal of Nutrition 1935 10 1 63 79
68. Colman R. J., Anderson R. M., Johnson S. C., Kastman E. K., Kosmatka K. J., Beasley T. M., Allison D. B., Cruzen C., Simmons H. A., Kemnitz J. W., Weindruch R., Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 2009 325 5937 201 204 2-s2.0-67650439330 10.1126/science. 1173635
69. Anderson R., Weindruch R., Metabolic reprogramming in dietary restriction. Interdisciplinary Topics in Gerontology 2007 35 18 38 2-s2.0-38349155931 10.1159/000096554
70. Kennedy B. K., Steffen K. K., Kaeberlein M., Ruminations on dietary restriction and aging. Cellular and Molecular Life Sciences 2007 64 11 1323 1328 2-s2.0-34249980038 10.1007/s00018-007-6470-y (Pubitemid 46889228)
71. Piper M. D. W., Bartke A., Diet and aging. Cell Metabolism 2008 8 2 99 104 2-s2.0-48149112576 10.1016/j.cmet.2008.06.012
72. Roth G. S., Ingram D. K., Lane M. A., Caloric restriction in primates and relevance to humans. Annals of the New York Academy of Sciences 2001 928 305 315 2-s2.0-0035040547 (Pubitemid 32386092)
73. Walford R. L., Mock D., Verdery R., MacCallum T., Calorie restriction in biosphere 2: alterations in physiologic, hematologic, hormonal, and biochemical parameters in humans restricted for a 2-year period. The Journals of Gerontology A 2002 57 6 B211 B224 2-s2.0-0036265323 (Pubitemid 34575720)
74. Fontana L., Meyer T. E., Klein S., Holloszy J. O., Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans. Proceedings of the National Academy of Sciences of the United States of America 2004 101 17 6659 6663 2-s2.0-2342647592 10.1073/pnas.0308291101 (Pubitemid 38586030)
75. Tsagareli V., Noakes M., Norman R. J., Effect of a very-low-calorie diet on in vitro fertilization outcomes. Fertility and Sterility 2006 86 1 227 229 2-s2.0-33745511077 10.1016/j.fertnstert.2005.12.041 (Pubitemid 43962964)
76. Heilbronn L. K., De Jonge L., Frisard M. I., DeLany J. P., Larson-Meyer D. E., Rood J., Nguyen T., Martin C. K., Volaufova J., Most M. M., Greenway F. L., Smith S. R., Deutsch W. A., Williamson D. A., Ravussin E., Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: a randomized controlled trial. Journal of the American Medical Association 2006 295 13 1539 1548 2-s2.0-33645526333 10.1001/jama.295.13.1539
77. Racette S. B., Weiss E. P., Villareal D. T., Arif H., Steger-May K., Schechtman K. B., Fontana L., Klein S., Holloszy J. O., One year of caloric restriction in humans: feasibility and effects on body composition and abdominal adipose tissue. The Journals of Gerontology A 2006 61 9 943 950 2-s2.0-33748805784 (Pubitemid 44413933)
78. Meyer T. E., Kovács S. J., Ehsani A. A., Klein S., Holloszy J. O., Fontana L., Long-term caloric restriction ameliorates the decline in diastolic function in humans. Journal of the American College of Cardiology 2006 47 2 398 402 2-s2.0-30344435943 10.1016/j.jacc.2005.08.069 (Pubitemid 43063261)
79. Fontana L., Klein S., Holloszy J. O., Premachandra B. N., Effect of long-term calorie restriction with adequate protein and micronutrients on thyroid hormones. The Journal of Clinical Endocrinology & Metabolism 2006 91 8 3232 3235 2-s2.0-33747645526 10.1210/jc.2006-0328 (Pubitemid 44271782)
80. Fontana L., Klein S., Aging, adiposity, and calorie restriction. Journal of the American Medical Association 2007 297 9 986 994 2-s2.0-33847764645 10.1001/jama.297.9.986 (Pubitemid 46380237)
81. Holloszy J. O., Fontana L., Caloric restriction in humans. Experimental Gerontology 2007 42 8 709 712 2-s2.0-34447316421 10.1016/j.exger.2007.03.009 (Pubitemid 47058857)
82. Willcox B. J., Willcox D. C., Todoriki H., Fujiyoshi A., Yano K., He Q., Curb J. D., Suzuki M., Caloric restriction, the traditional okinawan diet, and healthy aging: the diet of the world's longest-lived people and its potential impact on morbidity and life span. Annals of the New York Academy of Sciences 2007 1114 434 455 2-s2.0-35948936851 10.1196/annals.1396.037 (Pubitemid 350070404)
83. Fontana L., Villareal D. T., Weiss E. P., Racette S. B., Steger-May K., Klein S., Holloszy J. O., Calorie restriction or exercise: effects on coronary heart disease risk factors. A randomized, controlled trial. American Journal of Physiology 2007 293 1 E197 E202 2-s2.0-34547223572 10.1152/ajpendo.00102.2007 (Pubitemid 47108169)
84. Holloszy J. O., Fontana L., Caloric restriction in humans. Experimental Gerontology 2007 42 8 709 712 2-s2.0-34447316421 10.1016/j.exger.2007.03.009 (Pubitemid 47058857)
85. Hofer T., Fontana L., Anton S. D., Weiss E. P., Villareal D., Malayappan B., Leeuwenburgh C., Long-term effects of caloric restriction or exercise on DNA and RNA oxidation levels in white blood cells and urine in humans. Rejuvenation Research 2008 11 4 793 799 2-s2.0-50449096909 10.1089/rej.2008.0712
86. Redman L. M., Rood J., Anton S. D., Champagne C., Smith S. R., Ravussin E., Calorie restriction and bone health in young, overweight individuals. Archives of Internal Medicine 2008 168 17 1859 1866 2-s2.0-52649158793 10.1001/archinte.168.17.1859
87. Cruzen C., Colman R. J., Effects of caloric restriction on cardiovascular aging in non-human primates and humans. Clinics in Geriatric Medicine 2009 25 4 733 743 2-s2.0-70449864788 10.1016/j.cger.2009.07.001
88. Cangemi R., Friedmann A. J., Holloszy J. O., Fontana L., Long-term effects of calorie restriction on serum sex-hormone concentrations in men. Aging Cell 2010 9 2 236 242 2-s2.0-77953239921 10.1111/j.1474-9726.2010.00553.x
89. Trepanowski J. F., Bloomer R. J., The impact of religious fasting on human health. Nutrition Journal 2010 9 1, article 57 2-s2.0-78549270120 10.1186/1475-2891-9-57
90. Soare A., Cangemi R., Omodei D., Holloszy J. O., Fontana L., Long-term calorie restriction, but not endurance exercise, lowers core body temperature in humans. Aging 2011 3 4 374 379
91. Rochon J., Bales C. W., Ravussin E., Redman L. M., Holloszy J. O., Racette S. B., Roberts S. B., Das S. K., Romashkan S., Galan K. M., Hadley E. C., Kraus W. E., Design and conduct of the CALERIE study: comprehensive assessment of the long-term effects of reducing intake of energy. The Journals of Gerontology A 2011 66 1 97 108 2-s2.0-79951631209 10.1093/gerona/glq168
92. Martin C. K., Das S. K., Lindblad L., Racette S. B., McCrory M. A., Weiss E. P., DeLany J. P., Kraus W. E., Effect of calorie restriction on the free-living physical activity levels of nonobese humans: results of three randomized trials. Journal of Applied Physiology 2011 110 4 956 963 2-s2.0-79954589262 10.1152/japplphysiol.00846.2009
93. Stein K., Soare A., Meyer T. E., Cangemi R., Holloszy J. O., Fontana L., Caloric restriction may reverse age-related autonomic decline in humans. Aging Cell 2012 11 4 644 650
94. Anderson R. M., Weindruch R., Metabolic reprogramming, caloric restriction and aging. Trends in Endocrinology and Metabolism 2010 21 3 134 141 2-s2.0-77949318560 10.1016/j.tem.2009.11.005
95. Zahn J. M., Poosala S., Owen A. B., Ingram D. K., Lustig A., Carter A., Weeraratna A. T., Taub D. D., Gorospe M., Mazan-Mamczarz K., Lakatta E. G., Boheler K. R., Xu X., Mattson M. P., Falco G., Ko M. S., Schlessinger D., Firman J., Kummerfeld S. K., Wood W. H., Zonderman A. B., Kim S. K., Becker K. G., AGEMAP: a gene expression database for aging in mice. PLoS Genetics 2007 3 11 e201 2-s2.0-38949131934 10.1371/journal.pgen.0030201 (Pubitemid 350291590)
96. de Magalhães J. P., Curado J., Church G. M., Meta-analysis of age-related gene expression profiles identifies common signatures of aging. Bioinformatics 2009 25 7 875 881 2-s2.0-63549135460 10.1093/bioinformatics/ btp073
97. Park S. K., Prolla T. A., Lessons learned from gene expression profile studies of aging and caloric restriction. Ageing Research Reviews 2005 4 1 55 65 2-s2.0-11144321344 10.1016/j.arr.2004.09.003 (Pubitemid 40037554)
98. Hotamisligil G. S., Inflammation and metabolic disorders. Nature 2006 444 7121 860 867 2-s2.0-33845866857 10.1038/nature05485 (Pubitemid 46024993)
99. Lago F., Dieguez C., Gómez-Reino J., Gualillo O., The emerging role of adipokines as mediators of inflammation and immune responses. Cytokine & Growth Factor Reviews 2007 18 3-4 313 325 2-s2.0-34249983235 10.1016/j.cytogfr.2007.04.007 (Pubitemid 46891288)
100. Meier U., Gressner A. M., Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clinical Chemistry 2004 50 9 1511 1525 2-s2.0-4344607526 10.1373/clinchem.2004.032482 (Pubitemid 39121218)
101. Zhu M., Lee G. D., Ding L., Hu J., Qiu G., de Cabo R., Bernier M., Ingram D. K., Zou S., Adipogenic signaling in rat white adipose tissue: modulation by aging and calorie restriction. Experimental Gerontology 2007 42 8 733 744 2-s2.0-34447536512 10.1016/j.exger.2007.05.011 (Pubitemid 47064498)
102. Shinmura K., Tamaki K., Saito K., Nakano Y., Tobe T., Bolli R., Cardioprotective effects of short-term caloric restriction are mediated by adiponectin via activation of AMP-activated protein kinase. Circulation 2007 116 24 2809 2817 2-s2.0-37349051709 10.1161/CIRCULATIONAHA.107.725697 (Pubitemid 350291223)
103. Díez J. J., Iglesias P., The role of the novel adipocyte-derived hormone adiponectin in human disease. European Journal of Endocrinology 2003 148 3 293 300 2-s2.0-0037356826 10.1530/eje.0.1480293 (Pubitemid 36410714)
104. Ukkola O., Santaniemi M., Adiponectin: a link between excess adiposity and associated comorbidities? Journal of Molecular Medicine 2002 80 11 696 702 2-s2.0-0036432925 10.1007/s00109-002-0378-7 (Pubitemid 35352035)
105. Renaldi O., Pramono B., Sinorita H., Purnomo L. B., Asdie R. H., Asdie A. H., Hypoadiponectinemia: a risk factor for metabolic syndrome. Acta medica Indonesiana 2009 41 1 20 24 2-s2.0-77952515176
106. Civitarese A. E., Ukropcova B., Carling S., Hulver M., DeFronzo R. A., Mandarino L., Ravussin E., Smith S. R., Role of adiponectin in human skeletal muscle bioenergetics. Cell Metabolism 2006 4 1 75 87 2-s2.0-33745419401 10.1016/j.cmet.2006.05.002 (Pubitemid 43942255)
107. Nishimura M., Izumiya Y., Higuchi A., Shibata R., Qiu J., Kudo C., Shin H. K., Moskowitz M. A., Ouchi N., Adiponectin prevents cerebral ischemic injury through endothelial nitric oxide synthase-dependent mechanisms. Circulation 2008 117 2 216 223 2-s2.0-38049178556 10.1161/CIRCULATIONAHA.107.725044
108. Fernández-Real J. M., López-Bermejo A., Casamitjana R., Ricart W., Novel interactions of adiponectin with the endocrine system and inflammatory parameters. The Journal of Clinical Endocrinology & Metabolism 2003 88 6 2714 2718 2-s2.0-0037902967 (Pubitemid 36724447)
109. Aldhahi W., Hamdy O., Adipokines, inflammation, and the endothelium in diabetes. Current Diabetes Reports 2003 3 4 293 298 2-s2.0-0141448772 (Pubitemid 38906785)
110. Ouchi N., Kihara S., Funahashi T., Matsuzawa Y., Walsh K., Obesity, adiponectin and vascular inflammatory disease. Current Opinion in Lipidology 2003 14 6 561 566 2-s2.0-0347334429 10.1097/00041433-200312000-00003 (Pubitemid 41623184)
111. Huffman D. M., Moellering D. R., Grizzle W. E., Stockard C. R., Johnson M. S., Nagy T. R., Effect of exercise and calorie restriction on biomarkers of aging in mice. American Journal of Physiology 2008 294 5 R1618 R1627 2-s2.0-45549091810 10.1152/ajpregu.00890.2007
112. Fontana L., Weiss E. P., Villareal D. T., Klein S., Holloszy J. O., Long-term effects of calorie or protein restriction on serum IGF-1 and IGFBP-3 concentration in humans. Aging Cell 2008 7 5 681 687 2-s2.0-52449087974 10.1111/j.1474-9726.2008.00417.x
113. Cameron A. R., Anton S., Melville L., Houston N. P., Dayal S., Mcdougall G. J., Stewart D., Rena G., Black tea polyphenols mimic insulin/insulin-like growth factor-1 signalling to the longevity factor FOXO1a. Aging Cell 2008 7 1 69 77 2-s2.0-38349167559 10.1111/j.1474-9726.2007.00353.x
114. Qin W., Zhao W., Ho L., Wang J., Walsh K., Gandy S., Pasinetti G. M., Regulation of forkhead transcription factor FOXO3a contributes to calorie restriction-induced prevention of Alzheimer's disease-type amyloid neuropathology and spatial memory deterioration. Annals of the New York Academy of Sciences 2008 1147 335 347 2-s2.0-57649155899 10.1196/annals.1427.024
115. Flachsbart F., Caliebe A., Kleindorp R., Blanché H., Von Eller-Eberstein H., Nikolaus S., Schreiber S., Nebel A., Association of FOX03A variation with human longevity confirmed in German centenarians. Proceedings of the National Academy of Sciences of the United States of America 2009 106 8 2700 2705 2-s2.0-62449083712 10.1073/pnas.0809594106
116. 2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. The Journal of Clinical Investigation 2009 119 3 573 581 2-s2.0-67650815430 10.1172/JCI37048
117. Harrison D. E., Strong R., Sharp Z. D., Nelson J. F., Astle C. M., Flurkey K., Nadon N. L., Wilkinson J. E., Frenkel K., Carter C. S., Pahor M., Javors M. A., Fernandez E., Miller R. A., Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 2009 460 7253 392 395 2-s2.0-67650944993 10.1038/nature08221
118. Chen C., Liu Y., Liu Y., Zheng P., mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells. Science Signaling 2009 2 98 ra75 2-s2.0-75549090275 10.1126/scisignal.2000559
119. Kapahi P., Chen D., Rogers A. N., Katewa S. D., Li P. W. L., Thomas E. L., Kockel L., With TOR, less is more: a key role for the conserved nutrient-sensing TOR pathway in aging. Cell Metabolism 2010 11 6 453 465 2-s2.0-77955747346 10.1016/j.cmet.2010.05.001
120. Zid B. M., Rogers A. N., Katewa S. D., Vargas M. A., Kolipinski M. C., Lu T. A., Benzer S., Kapahi P., 4E-BP extends lifespan upon dietary restriction by enhancing mitochondrial activity in Drosophila. Cell 2009 139 1 149 160 2-s2.0-70349438679 10.1016/j.cell.2009.07.034
121. Sengupta S., Peterson T. R., Laplante M., Oh S., Sabatini D. M., mTORC1 controls fasting-induced ketogenesis and its modulation by ageing. Nature 2010 468 7327 1100 1106 2-s2.0-78650848337 10.1038/nature09584
122. Cunningham J. T., Rodgers J. T., Arlow D. H., Vazquez F., Mootha V. K., Puigserver P., mTOR controls mitochondrial oxidative function through a YY1-PGC-1 α transcriptional complex. Nature 2007 450 7170 736 740 2-s2.0-36749081539 10.1038/nature06322 (Pubitemid 350207689)
123. Ramanathan A., Schreiber S. L., Direct control of mitochondrial function by mTOR. Proceedings of the National Academy of Sciences of the United States of America 2009 106 52 22229 22232 2-s2.0-76049099052 10.1073/pnas.0912074106
124. Knapowski J., Wieczorowska-Tobis K., Witowski J., Pathophysiology of ageing. Journal of Physiology and Pharmacology 2002 53 2 135 146 2-s2.0-0036291540 (Pubitemid 34717236)
125. Issa J. P. J., Ahuja N., Toyota M., Bronner M. P., Brentnall T. A., Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Research 2001 61 9 3573 3577 2-s2.0-0035328527 (Pubitemid 32694963)
126. Issa J. P. J., Ottaviano Y. L., Celano P., Hamilton S. R., Davidson N. E., Baylin S. B., Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nature Genetics 1994 7 4 536 540 2-s2.0-0028001087 10.1038/ng0894-536 (Pubitemid 24308343)
127. Issa J. P. J., Vertino P. M., Boehm C. D., Newsham I. F., Baylin S. B., Switch from monoallelic to biallelic human IGF2 promoter methylation during aging and carcinogenesis. Proceedings of the National Academy of Sciences of the United States of America 1996 93 21 11757 11762 2-s2.0-0029976873 10.1073/pnas.93.21.11757 (Pubitemid 26347196)
128. Singhal R. P., Mays-Hoopes L. L., Eichhorn G. L., DNA methylation in aging of mice. Mechanisms of Ageing and Development 1987 41 3 199 210 2-s2.0-0023546949 (Pubitemid 18015550)
129. Waki T., Tamura G., Sato M., Motoyama T., Age-related methylation of tumor suppressor and tumor-related genes: an analysis of autopsy samples. Oncogene 2003 22 26 4128 4133 2-s2.0-0038339107 10.1038/sj.onc.1206651 (Pubitemid 36819653)
130. Wilson V. L., Smith R. A., Ma S., Cutler R. G., Genomic 5-methyldeoxycytidine decreases with age. The Journal of Biological Chemistry 1987 262 21 9948 9951 2-s2.0-0023664725
131. Kim T. Y., Lee H. J., Hwang K. S., Lee M., Kim J. W., Bang Y. J., Kang G. H., Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma. Laboratory Investigation 2004 84 4 479 484 2-s2.0-2342641616 10.1038/labinvest.3700060 (Pubitemid 41656475)
132. Li Y., Daniel M., Tollefsbol T. O., Epigenetic regulation of caloric restriction in aging. BMC Medicine 2011 9, article 98
133. Vaquero A., Reinberg D., Calorie restriction and the exercise of chromatin. Genes & Development 2009 23 16 1849 1869 2-s2.0-69249235740 10.1101/gad.1807009
134. Muñoz-Najar U., Sedivy J. M., Epigenetic control of aging. Antioxidants & Redox Signaling 2011 14 2 241 259 2-s2.0-78650273646 10.1089/ars.2010.3250
135. Hass B. S., Hart R. W., Lu M. H., Lyn-Cook B. D., Effects of caloric restriction in animals on cellular function, oncogene expression, and DNA methylation in vitro. Mutation Research 1993 295 46 281 289 2-s2.0-0027745794 (Pubitemid 24043521)
136. Li Y., Liu L., Tollefsbol T. O., Glucose restriction can extend normal cell lifespan and impair precancerous cell growth through epigenetic control of hTERT and p16 expression. The FASEB Journal 2010 24 5 1442 1453 2-s2.0-77952305618 10.1096/fj.09-149328
137. Ahima R. S., Connecting obesity, aging and diabetes. Nature Medicine 2009 15 9 996 997 2-s2.0-69949187615 10.1038/nm0909-996
138. Larsen T. M., Dalskov S., Van Baak M., Jebb S., Kafatos A., Pfeiffer A., Martinez J. A., Handjieva-Darlenska T., Kunešová M., Holst C., Saris W. H. M., Astrup A., The diet, obesity and genes (diogenes) dietary study in eight European countriesa comprehensive design for long-term intervention.
139. Milagro F. I., Campión J., Cordero P., Goyenechea E., Gómez-Uriz A. M., Abete I., Zulet M. A., Martínez J. A., A dual epigenomic approach for the search of obesity biomarkers: DNA methylation in relation to diet-induced weight loss. The FASEB Journal 2011 25 4 1378 1389 2-s2.0-79954611176 10.1096/fj.10-170365
140. Bouchard L., Rabasa-Lhoret R., Faraj M., Lavoie M. È., Mill J., Pérusse L., Vohl M. C., Differential epigenomic and transcriptomic responses in subcutaneous adipose tissue between low and high responders to caloric restriction. The American Journal of Clinical Nutrition 2010 91 2 309 320 2-s2.0-75649087405 10.3945/ajcn.2009.28085
141. Campión J., Milagro F. I., Goyenechea E., Martínez J. A., TNF- α promoter methylation as a predictive biomarker for weight-loss response. Obesity 2009 17 6 1293 1297 2-s2.0-67650466971 10.1038/oby.2008.679
142. Clayton A. L., Hazzalin C. A., Mahadevan L. C., Enhanced histone acetylation and transcription: a dynamic perspective. Molecular Cell 2006 23 3 289 296 2-s2.0-33746457753 10.1016/j.molcel.2006.06.017 (Pubitemid 44128853)
143. Meyerson M., Counter C. M., Eaton E. N., Ellisen L. W., Steiner P., Caddle S. D., Ziaugra L., Beijersbergen R. L., Davidoff M. J., Qingyun L., Bacchetti S., Haber D. A., Weinberg R. A., hEST2, the putative human telomerase catalytic subunit gene, is up- regulated in tumor cells and during immortalization. Cell 1997 90 4 785 795 2-s2.0-0030745448 10.1016/S0092-8674(00) 80538-3 (Pubitemid 27357969)
144. Kanaya T., Kyo S., Takakura M., Ito H., Namiki M., Inoue M., hTERT is a critical determinant of telomerase activity in renal-cell carcinoma. International Journal of Cancer 1998 78 5 539 543 (Pubitemid 28507174)
145. Lin S. J., Defossez P. A., Guarente L., Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science 2000 289 5487 2126 2128 2-s2.0-0034703217 10.1126/science.289.5487.2126
146. Guarente L., Picard F., Calorie restrictionthe SIR2 connection. Cell 2005 120 4 473 482 2-s2.0-13944253348 10.1016/j.cell.2005.01.029 (Pubitemid 40269762)
147. Leibiger I. B., Berggren P. O., Sirt1: a metabolic master switch that modulates lifespan. Nature Medicine 2006 12 1 34 36 2-s2.0-30044440497 10.1038/nm0106-34
148. Bordone L., Cohen D., Robinson A., Motta M. C., Van Veen E., Czopik A., Steele A. D., Crowe H., Marmor S., Luo J., Gu W., Guarente L., SIRT1 transgenic mice show phenotypes resembling calorie restriction. Aging Cell 2007 6 6 759 767 2-s2.0-36248975293 10.1111/j.1474-9726.2007.00335.x (Pubitemid 350131044)
149. Cohen H. Y., Miller C., Bitterman K. J., Wall N. R., Hekking B., Kessler B., Howitz K. T., Gorospe M., De Cabo R., Sinclair D. A., Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 2004 305 5682 390 392 2-s2.0-3142740860 10.1126/science.1099196 (Pubitemid 38938153)
150. Kanfi Y., Peshti V., Gozlan Y. M., Rathaus M., Gil R., Cohen H. Y., Regulation of SIRT1 protein levels by nutrient availability. FEBS Letters 2008 582 16 2417 2423 2-s2.0-45549102566 10.1016/j.febslet.2008.06.005
151. Crujeiras A. B., Parra D., Goyenechea E., Martínez J. A., Sirtuin gene expression in human mononuclear cells is modulated by caloric restriction. European Journal of Clinical Investigation 2008 38 9 672 678 2-s2.0-49749088697 10.1111/j.1365-2362.2008.01998.x
152. Wakeling L. A., Ions L. J., Ford D., Could Sirt1-mediated epigenetic effects contribute to the longevity response to dietary restriction and be mimicked by other dietary interventions? Age 2009 31 4 327 341 2-s2.0-75949098771 10.1007/s11357-009-9104-5
153. INK4a suppression by glucose restriction contributes to human cellular lifespan extension through SIRT1-mediated epigenetic and genetic mechanisms. PLoS ONE 2011 6 2 2-s2.0-79952083769 10.1371/journal.pone.0017421 e17421
154. Haigis M. C., Guarente L. P., Mammalian sirtuinsemerging roles in physiology, aging, and calorie restriction. Genes & Development 2006 20 21 2913 2921 2-s2.0-33751113602 10.1101/gad.1467506 (Pubitemid 44771725)
155. Luo J., Nikolaev A. Y., Imai S. I., Chen D., Su F., Shiloh A., Guarente L., Gu W., Negative control of p53 by Sir2 α promotes cell survival under stress. Cell 2001 107 2 137 148 2-s2.0-0035913911 10.1016/S0092-8674(01)00524-4 (Pubitemid 33035941)
156. Langley E., Pearson M., Faretta M., Bauer U. M., Frye R. A., Minucci S., Pelicci P. G., Kouzarides T., Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. The EMBO Journal 2002 21 10 2383 2396 2-s2.0-0037093346 10.1093/emboj/21.10.2383 (Pubitemid 34546711)
157. SIRT1 functions as an NAD-dependent p53 deacetylase. Cell 2001 107 2 149 159 2-s2.0-0035913903 10.1016/S0092-8674(01)00527-X (Pubitemid 33035942)
158. Brunet A., Sweeney L. B., Sturgill J. F., Chua K. F., Greer P. L., Lin Y., Tran H., Ross S. E., Mostoslavsy R., Cohen H. Y., Hu L. S., Cheng H. L., Jedrychowski M. P., Gygi S. P., Sinclair D. A., Alt F. W., Greenberg M. E., Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004 303 5666 2011 2015 2-s2.0-12144290563 10.1126/science.1094637 (Pubitemid 38393275)
159. Motta M. C., Divecha N., Lemieux M., Kamel C., Chen D., Gu W., Bultsma Y., McBurney M., Guarente L., Mammalian SIRT1 represses forkhead transcription factors. Cell 2004 116 4 551 563 2-s2.0-1342264308 10.1016/S0092-8674(04)00126-6 (Pubitemid 38264432)
160. Schilling M. M., Oeser J. K., Boustead J. N., Flemming B. P., O'Brien R. M., Gluconeogenesis: re-evaluating the FOXO1-PGC-1 α connection. Nature 2006 443 7111 E10 E11 2-s2.0-33749545356 10.1038/nature05288 (Pubitemid 44529662)
161. Vega R. B., Huss J. M., Kelly D. P., The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor α in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Molecular and Cellular Biology 2000 20 5 1868 1876 2-s2.0-0033977890 10.1128/MCB.20.5.1868-1876.2000 (Pubitemid 30100203)
162. Koubova J., Guarente L., How does calorie restriction work? Genes & Development 2003 17 3 313 321 2-s2.0-0037312020 10.1101/gad.1052903 (Pubitemid 36182188)
163. Sohal R. S., Weindruch R., Oxidative stress, caloric restriction, and aging. Science 1996 273 5271 59 63 2-s2.0-0030038103 (Pubitemid 26255420)
164. Merry B. J., Molecular mechanisms linking calorie restriction and longevity. The International Journal of Biochemistry & Cell Biology 2002 34 11 1340 1354 2-s2.0-0036828603 10.1016/S1357-2725(02)00038-9 (Pubitemid 35245394)
165. Jeong J., Juhn K., Lee H., Kim S. H., Min B. H., Lee K. M., Cho M. H., Park G. H., Lee K. H., SIRT1 promotes DNA repair activity and deacetylation of Ku70. Experimental & Molecular Medicine 2007 39 1 8 13 2-s2.0-33847647624 (Pubitemid 46356001)
166. Cohen H. Y., Lavu S., Bitterman K. J., Hekking B., Imahiyerobo T. A., Miller C., Frye R., Ploegh H., Kessler B. M., Sinclair D. A., Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis. Molecular Cell 2004 13 5 627 638 2-s2.0-12144286529 10.1016/S1097-2765(04)00094-2 (Pubitemid 38368121)
167. Wong H., Riabowol K., Differential CDK-inhibitor gene expression in aging human diploid fibroblasts. Experimental Gerontology 1996 31 1-2 311 325 2-s2.0-0029944622 10.1016/0531-5565(95)00025-9 (Pubitemid 26079682)
168. Gil J., Peters G., Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nature Reviews 2006 7 9 667 677 2-s2.0-33747587608 10.1038/nrm1987 (Pubitemid 44268212)
169. Krishnamurthy J., Torrice C., Ramsey M. R., Kovalev G. I., Al-Regaiey K., Su L., Sharpless N. E., Ink4a/Arf expression is a biomarker of aging. The Journal of Clinical Investigation 2004 114 9 1299 1307 2-s2.0-13944251605 10.1172/JCI200422475 (Pubitemid 40385301)
170. Alcorta D. A., Xiong Y., Phelps D., Hannon G., Beach D., Barrett J. C., Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proceedings of the National Academy of Sciences of the United States of America 1996 93 24 13742 13747 2-s2.0-0030477686 10.1073/pnas.93.24.13742 (Pubitemid 26424190)
171. Melk A., Schmidt B. M. W., Takeuchi O., Sawitzki B., Rayner D. C., Halloran P. F., Expression of p 16 INK 4 a and other cell cycle regulator and senescence associated genes in aging human kidney. Kidney International 2004 65 2 510 520 2-s2.0-1642561702 10.1111/j.1523-1755.2004.00438.x (Pubitemid 38130645)
172. Fischle W., Wang Y., Allis C. D., Histone and chromatin cross-talk. Current Opinion in Cell Biology 2003 15 2 172 183 2-s2.0-0037376199 10.1016/S0955-0674(03)00013-9 (Pubitemid 36332192)
173. Kouzarides T., Histone methylation in transcriptional control. Current Opinion in Genetics & Development 2002 12 2 198 209 2-s2.0-0036532202 10.1016/S0959-437X(02)00287-3 (Pubitemid 34219493)
174. Noren Hooten N., Abdelmohsen K., Gorospe M., Ejiogu N., Zonderman A. B., Evans M. K., microRNA expression patterns reveal differential expression of target genes with age. PloS One 2010 5 5 e10724 2-s2.0-77956292106 10.1371/journal.pone.0010724
175. De Lencastre A., Pincus Z., Zhou K., Kato M., Lee S. S., Slack F. J., MicroRNAs both promote and antagonize longevity in C. elegans. Current Biology 2010 20 24 2159 2168 2-s2.0-78650490230 10.1016/j.cub.2010.11.015
176. Bates D. J., Li N., Liang R., Sarojini H., An J., Masternak M. M., Bartke A., Wang E., MicroRNA regulation in Ames dwarf mouse liver may contribute to delayed aging. Aging Cell 2010 9 1 1 18 2-s2.0-76249107865 10.1111/j.1474-9726. 2009.00529.x
177. Orom U. A., Lim M. K., Savage J. E., Jin L., Saleh A. D., Lisanti M. P., Simone N. L., MicroRNA-203 regulates caveolin-1 in breast tissue during caloric restriction. Cell Cycle 2012 11 7 1291 1295
178. Khanna A., Muthusamy S., Liang R., Sarojini H., Wang E., Gain of survival signaling by down-regulation of three key miRNAs in brain of calorie-restricted mice. Aging 2011 3 3 223 236
179. Paradis E., Douillard H., Koutroumanis M., Goodyer C., LeBlanc A., Amyloid β peptide of Alzheimer's disease downregulates bcl-2 and upregulates bax expression in human neurons. Journal of Neuroscience 1996 16 23 7533 7539 2-s2.0-0029860523 (Pubitemid 26389692)
180. Perier C., Bové J., Wu D. C., Dehay B., Choi D. K., Jackson-Lewis V., Rathke-Hartlieb S., Bouillet P., Strasser A., Schulz J. B., Przedborski S., Vila M., Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America 2007 104 19 8161 8166 2-s2.0-34249947154 10.1073/pnas.0609874104 (Pubitemid 47185892)
181. Louneva N., Cohen J. W., Han L. Y., Talbot K., Wilson R. S., Bennett D. A., Trojanowski J. Q., Arnold S. E., Caspase-3 is enriched in postsynaptic densities and increased in Alzheimer's disease. The American Journal of Pathology 2008 173 5 1488 1495 2-s2.0-55349115428 10.2353/ajpath.2008.080434
182. Yamada M., Kida K., Amutuhaire W., Ichinose F., Kaneki M., Gene disruption of caspase-3 prevents MPTP-induced Parkinson's disease in mice. Biochemical and Biophysical Research Communications 2010 402 2 312 318 2-s2.0-78149468522 10.1016/j.bbrc.2010.10.023
183. Kudo W., Lee H. P., Smith M. A., Zhu X., Matsuyama S., Lee H. G., Inhibition of Bax protects neuronal cells from oligomeric A β neurotoxicity. Cell Death & Disease 2012 3 e309 10.1038/cddis.2012.43
184. Ingram D. K., Zhu M., Mamczarz J., Zou S., Lane M. A., Roth G. S., deCabo R., Calorie restriction mimetics: an emerging research field. Aging Cell 2006 5 2 97 108 2-s2.0-33646948539 10.1111/j.1474-9726.2006.00202.x (Pubitemid 44056501)
185. Warner H. R., Ingram D., Miller R. A., Nadon N. L., Richardson A. G., Program for testing biological interventions to promote healthy aging. Mechanisms of Ageing and Development 2000 115 3 199 207 2-s2.0-0343962628 10.1016/S0047-6374(00)00118-4 (Pubitemid 30445214)
186. Nadon N. L., Strong R., Miller R. A., Nelson J., Javors M., Sharp Z. D., Peralba J. M., Harrison D. E., Design of aging intervention studies: the NIA interventions testing program. Age 2008 30 4 187 199 2-s2.0-56749182467 10.1007/s11357-008-9048-1
187. Miller R. A., Harrison D. E., Astle C. M., Floyd R. A., Flurkey K., Hensley K. L., Javors M. A., Leeuwenburgh C., Nelson J. F., Ongini E., Nadon N. L., Warner H. R., Strong R., An aging interventions testing program: study design and interim report. Aging Cell 2007 6 4 565 575 2-s2.0-34447635239 10.1111/j.1474-9726.2007.00311.x (Pubitemid 47087061)
188. Strong R., Miller R. A., Astle C. M., Floyd R. A., Flurkey K., Hensley K. L., Javors M. A., Leeuwenburgh C., Nelson J. F., Ongini E., Nadon N. L., Warner H. R., Harrison D. E., Nordihydroguaiaretic acid and aspirin increase lifespan of genetically heterogeneous male mice. Aging Cell 2008 7 5 641 650 2-s2.0-52449114485 10.1111/j.1474-9726.2008.00414.x
189. Nadon N. L., Exploiting the rodent model for studies on the pharmacology of lifespan extension. Aging Cell 2006 5 1 9 15 2-s2.0-33644789792 10.1111/j.1474-9726.2006.00185.x (Pubitemid 43348957)
190. Holloszy J. O., Mortality rate and longevity of food-restricted exercising male rats: a reevaluation. Journal of Applied Physiology 1997 82 2 399 403 2-s2.0-0031058447 (Pubitemid 27090162)
191. Deruisseau K. C., Kavazis A. N., Judge S., Murlasits Z., Deering M. A., Quindry J. C., Lee Y., Falk D. J., Leeuwenburgh C., Powers S. K., Moderate caloric restriction increases diaphragmatic antioxidant enzyme mRNA, but not when combined with lifelong exercise. Antioxidants & Redox Signaling 2006 8 3-4 539 547 2-s2.0-33646711670 10.1089/ars.2006.8.539 (Pubitemid 43741323)
192. Seo A. Y., Hofer T., Sung B., Judge S., Chung H. Y., Leeuwenburgh C., Hepatic oxidative stress during aging: effects of 8 long-term calorie restriction and lifelong exercise. Antioxidants & Redox Signaling 2006 8 3-4 529 538 2-s2.0-33646697132 10.1089/ars.2006.8.529 (Pubitemid 43741322)
193. Kalani R., Judge S., Carter C., Pahor M., Leeuwenburgh C., Effects of caloric restriction and exercise on age-related, chronic inflammation assessed by C-reactive protein and interleukin-6. The Journals of Gerontology A 2006 61 3 211 217 2-s2.0-33646012604
194. Abete P., Testa G., Galizia G., Mazzella F., Della Morte D., De Santis D., Calabrese C., Cacciatore F., Gargiulo G., Ferrara N., Rengo G., Sica V., Napoli C., Rengo F., Tandem action of exercise training and food restriction completely preserves ischemic preconditioning in the aging heart. Experimental Gerontology 2005 40 1-2 43 50 2-s2.0-19944432303 10.1016/j.exger.2004.10.005 (Pubitemid 40138745)
195. Crandall D. L., Feirer R. P., Griffith D. R., Beitz D. C., Relative role of caloric restriction and exercise training upon susceptibility to isoproterenol-induced myocardial infarction in male rats. The American Journal of Clinical Nutrition 1981 34 5 841 847 2-s2.0-0019794534 (Pubitemid 11077916)
196. Civitarese A. E., Carling S., Heilbronn L. K., Hulver M. H., Ukropcova B., Deutsch W. A., Smith S. R., Ravussin E., Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS Medicine 2007 4 3, article e76 2-s2.0-33947710793 10.1371/journal.pmed.0040076 (Pubitemid 46495316)
197. Larson-Meyer D. E., Newcomer B. R., Heilbronn L. K., Volaufova J., Smith S. R., Alfonso A. J., Lefevre M., Rood J. C., Williamson D. A., Ravussin E., DeLany J., De Jonge L., Nguyen T., Martin C. K., Most M. M., Greenway F. L., York-Crow E., Anton S., Champagne C., Dahmer B., Deutsch A., Geiselman P., Howard J., Ihrig J., Marquis D., Murla C., Owens S., Stewart A., Tarver V., Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function. Obesity 2008 16 6 1355 1362 2-s2.0-44449171470 10.1038/oby.2008.201 (Pubitemid 351770499)
198. Lefevre M., Redman L. M., Heilbronn L. K., Smith J. V., Martin C. K., Rood J. C., Greenway F. L., Williamson D. A., Smith S. R., Ravussin E., Caloric restriction alone and with exercise improves CVD risk in healthy non-obese individuals. Atherosclerosis 2009 203 1 206 213 2-s2.0-60649110218 10.1016/j.atherosclerosis.2008.05.036
199. Larson-Meyer D. E., Redman L., Heilbronn L. K., Martin C. K., Ravussin E., Caloric restriction with or without exercise: the fitness versus fatness debate. Medicine and Science in Sports and Exercise 2010 42 1 152 159 2-s2.0-73449111908 10.1249/MSS.0b013e3181ad7f17
200. Silverman N. E., Nicklas B. J., Ryan A. S., Addition of aerobic exercise to a weight loss program increases BMD, with an associated reduction in inflammation in overweight postmenopausal women. Calcified Tissue International 2009 84 4 257 265 2-s2.0-63949088482 10.1007/s00223-009-9232-z
201. Trepanowski J. F., Canale R. E., Marshall K. E., Kabir M. M., Bloomer R. J., Impact of caloric and dietary restriction regimens on markers of health and longevity in humans and animals: a summary of available findings. Nutrition Journal 2011 10, article 107
202. Iwasaki K., Gleiser C. A., Masoro E. J., McMahan C. A., Seo E., Yu B. P., The influence of dietary protein source on longevity and age-related disease processes of Fischer rats. Journals of Gerontology 1988 43 1 B5 B12 2-s2.0-0023838776 (Pubitemid 18029928)
203. Shimokawa I., Higami Y., Yu B. P., Masoro E. J., Ikeda T., Influence of dietary components on occurrence of and mortality due to neoplasms in male F344 rats. Aging 1996 8 4 254 262 2-s2.0-0029836371
204. Khorakova M., Deil Z., Khausman D., Matsek K., Effect of carbohydrate-enriched diet and subsequent food restriction on life prolongation in Fischer 344 male rats. Fiziologicheskii Zhurnal 1990 36 5 16 21 2-s2.0-0025480419
205. Kubo C., Johnson B. C., Gajjar A., Good R. A., Crucial dietary factors in maximizing life span and longevity in autoimmune-prone mice. The Journal of Nutrition 1987 117 6 1129 1135 2-s2.0-0023350891
206. Pamplona R., Barja G., Mitochondrial oxidative stress, aging and caloric restriction: the protein and methionine connection. Biochimica et Biophysica Acta 2006 1757 5-6 496 508 2-s2.0-33745597874 10.1016/j.bbabio.2006.01.009 (Pubitemid 43993832)
207. Sanz A., Caro P., Sanchez J. G., Barja G., Effect of lipid restriction on mitochondrial free radical production and oxidative DNA damage. Annals of the New York Academy of Sciences 2006 1067 1 200 209 2-s2.0-33744534981 10.1196/annals.1354.024 (Pubitemid 43810005)
208. Sanz A., Gómez J., Caro P., Barja G., Carbohydrate restriction does not change mitochondrial free radical generation and oxidative DNA damage. Journal of Bioenergetics and Biomembranes 2006 38 5-6 327 333 2-s2.0-33845635647 10.1007/s10863-006-9051-0 (Pubitemid 44952976)
209. Segall P. E., Timiras P. S., Pathophysiologic findings after chronic tryptophan deficiency in rats: a model for delayed growth and aging. Mechanisms of Ageing and Development 1976 5 2 109 124 2-s2.0-0017111106
210. Ooka H., Segall P. E., Timiras P. S., Histology and survival in age-delayed low-tryptophan-fed rats. Mechanisms of Ageing and Development 1988 43 1 79 98 2-s2.0-0023839144 (Pubitemid 18085925)
211. Miller R. A., Buehner G., Chang Y., Harper J. M., Sigler R., Smith-Wheelock M., Methionine-deficient diet extends mouse lifespan, slows immune and lens aging, alters glucose, T4, IGF-I and insulin levels, and increases hepatocyte MIF levels and stress resistance. Aging Cell 2005 4 3 119 125 2-s2.0-23844464540 10.1111/j.1474-9726.2005.00152.x (Pubitemid 41602745)
212. Orentreich N., Matias J. R., DeFelice A., Zimmerman J. A., Low methionine ingestion by rats extends life span. The Journal of Nutrition 1993 123 2 269 274 2-s2.0-0027512877 (Pubitemid 23063011)
213. Richie J. P. Jr., Leutzinger Y., Parthasarathy S., Malloy V., Orentreich N., Zimmerman J. A., Methionine restriction increases blood glutathione and longevity in F344 rats. The FASEB Journal 1994 8 15 1302 1307 2-s2.0-0028557442
214. Richie J. P. Jr., Komninou D., Leutzinger Y., Kleinman W., Orentreich N., Malloy V., Zimmerman J. A., Tissue glutathione and cysteine levels in methionine-restricted rats. Nutrition 2004 20 9 800 805 2-s2.0-4344646479 10.1016/j.nut.2004.05.009 (Pubitemid 39120041)
215. Zimmerman J. A., Malloy V., Krajcik R., Orentreich N., Nutritional control of aging. Experimental Gerontology 2003 38 1-2 47 52 2-s2.0-0037240234 10.1016/S0531-5565(02)00149-3 (Pubitemid 36113261)
216. Sanz A., Caro P., Ayala V., Portero-Otin M., Pamplona R., Barja G., Methionine restriction decreases mitochondrial oxygen radical generation and leak as well as oxidative damage to mitochondrial DNA and proteins. The FASEB Journal 2006 20 8 1064 1073 2-s2.0-33745970444 10.1096/fj.05-5568com (Pubitemid 44943902)
217. Caro P., Gómez J., López-Torres M., Sánchez I., Naudí A., Jove M., Pamplona R., Barja G., Forty percent and eighty percent methionine restriction decrease mitochondrial ROS generation and oxidative stress in rat liver. Biogerontology 2008 9 3 183 196 2-s2.0-43249123912 10.1007/s10522-008-9130-1
218. Ruiz M. C., Ayala V., Portero-Otín M., Requena J. R., Barja G., Pamplona R., Protein methionine content and MDA-lysine adducts are inversely related to maximum life span in the heart of mammals. Mechanisms of Ageing and Development 2005 126 10 1106 1114 2-s2.0-24344474190 10.1016/j.mad.2005.04.005 (Pubitemid 41253862)
219. Hidiroglou N., Gilani G. S., Long L., Zhao X., Madere R., Cockell K., Belonge B., Ratnayake W. M. N., Peace R., The influence of dietary vitamin E, fat, and methionine on blood cholesterol profile, homocysteine levels, and oxidizability of low density lipoprotein in the gerbil. The Journal of Nutritional Biochemistry 2004 15 12 730 740 2-s2.0-10944270854 10.1016/j.jnutbio.2004.04.009 (Pubitemid 40018116)
220. Caro P., Gomez J., Sanchez I., Garcia R., López-Torres M., Naudí A., Portero-Otin M., Pamplona R., Barja G., Effect of 40 restriction of dietary amino acids (except methionine) on mitochondrial oxidative stress and biogenesis, AIF and SIRT1 in rat liver. Biogerontology 2009 10 5 579 592 2-s2.0-69249205647 10.1007/s10522-008-9200-4
221. McCarty M. F., Barroso-Aranda J., Contreras F., The low-methionine content of vegan diets may make methionine restriction feasible as a life extension strategy. Medical Hypotheses 2009 72 2 125 128 2-s2.0-57749196739 10.1016/j.mehy.2008.07.044
222. Varady K. A., Hellerstein M. K., Alternate-day fasting and chronic disease prevention: a review of human and animal trials. The American Journal of Clinical Nutrition 2007 86 1 7 13 2-s2.0-34447288233 (Pubitemid 47041587)
223. Anson R. M., Guo Z., de Cabo R., Iyun T., Rios M., Hagepanos A., Ingram D. K., Lane M. A., Mattson M. P., Intermittent fasting dissociates beneficial effects of dietary restriction on glucose metabolism and neuronal resistance to injury from calorie intake. Proceedings of the National Academy of Sciences of the United States of America 2003 100 10 6216 6220 2-s2.0-0038623652 10.1073/pnas.1035720100 (Pubitemid 36576956)
224. Descamps O., Riondel J., Ducros V., Roussel A. M., Mitochondrial production of reactive oxygen species and incidence of age-associated lymphoma in OF1 mice: effect of alternate-day fasting. Mechanisms of Ageing and Development 2005 126 11 1185 1191 2-s2.0-25144522561 10.1016/j.mad.2005.06.007 (Pubitemid 41356519)
225. Duan W., Guo Z., Jiang H., Ware M., Mattson M. P., Reversal of behavioral and metabolic abnormalities, and insulin resistance syndrome, by dietary restriction in mice deficient in brain-derived neurotrophic factor. Endocrinology 2003 144 6 2446 2453 2-s2.0-0037562083 10.1210/en.2002-0113 (Pubitemid 36629896)
226. Ahmet I., Wan R., Mattson M. P., Lakatta E. G., Talan M., Cardioprotection by intermittent fasting in rats. Circulation 2005 112 20 3115 3121 2-s2.0-30944453279 10.1161/CIRCULATIONAHA.105.563817 (Pubitemid 43113442)
227. Mager D. E., Wan R., Brown M., Cheng A., Wareski P., Abernethy D. R., Mattson M. P., Caloric restriction and intermittent fasting alter spectral measures of heart rate and blood pressure variability in rats. The FASEB Journal 2006 20 6 631 637 2-s2.0-33646227422 10.1096/fj.05-5263com (Pubitemid 44933307)
228. Pedersen C. R., Hagemann I., Bock T., Buschard K., Intermittent feeding and fasting reduces diabetes incidence in BB rats. Autoimmunity 1999 30 4 243 250 2-s2.0-0032872943 (Pubitemid 29484315)
229. Tikoo K., Tripathi D. N., Kabra D. G., Sharma V., Gaikwad A. B., Intermittent fasting prevents the progression of type I diabetic nephropathy in rats and changes the expression of Sir2 and p53. FEBS Letters 2007 581 5 1071 1078 2-s2.0-33847091642 10.1016/j.febslet.2007.02.006 (Pubitemid 46282743)
230. Wan R., Camandola S., Mattson M. P., Intermittent fasting and dietary supplementation with 2-deoxy-D-glucose improve functional and metabolic cardiovascular risk factors in rats. The FASEB Journal 2003 17 9 1133 1134 2-s2.0-0038718723
231. Heilbronn L. K., Smith S. R., Martin C. K., Anton S. D., Ravussin E., Alternate-day fasting in nonobese subjects: effects on body weight, body composition, and energy metabolism. The American Journal of Clinical Nutrition 2005 81 1 69 73 2-s2.0-13744262254 (Pubitemid 43073377)
232. Halberg N., Henriksen M., Söderhamn N., Stallknecht B., Ploug T., Schjerling P., Dela F., Effect of intermittent fasting and refeeding on insulin action in healthy men. Journal of Applied Physiology 2005 99 6 2128 2136 2-s2.0-28044434071 10.1152/japplphysiol.00683.2005 (Pubitemid 41691629)
233. Johnson J. B., Summer W., Cutler R. G., Martin B., Hyun D. H., Dixit V. D., Pearson M., Nassar M., Tellejohan R., Maudsley S., Carlson O., John S., Laub D. R., Mattson M. P., Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma. Free Radical Biology and Medicine 2007 42 5 665 674 2-s2.0-33846805626 10.1016/j.freeradbiomed.2006.12.005 (Pubitemid 46205148)
234. Dixit V. D., Yang H., Sayeed K. S., Stote K. S., Rumpler W. V., Baer D. J., Longo D. L., Mattson M. P., Taub D. D., Controlled meal frequency without caloric restriction alters peripheral blood mononuclear cell cytokine production. Journal of Inflammation 2011 8, article 6 2-s2.0-79952337627 10.1186/1476-9255-8-6
235. Howitz K. T., Bitterman K. J., Cohen H. Y., Lamming D. W., Lavu S., Wood J. G., Zipkin R. E., Chung P., Kisielewski A., Zhang L. L., Scherer B., Sinclair D. A., Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003 425 6954 191 196 2-s2.0-0141719702 10.1038/nature01960 (Pubitemid 37150899)
236. Wood J. G., Rogina B., Lavu S., Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 2004 430 7000 686 689 (Pubitemid 39061685)
237. Yang H., Baur J. A., Chen A., Miller C., Sinclair D. A., Design and synthesis of compounds that extend yeast replicative lifespan. Aging Cell 2007 6 1 35 43 2-s2.0-33846449466 10.1111/j.1474-9726.2006.00259.x (Pubitemid 46140138)
238. Valenzano D. R., Terzibasi E., Genade T., Cattaneo A., Domenici L., Cellerino A., Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate. Current Biology 2006 16 3 296 300 2-s2.0-31944450272 10.1016/j.cub.2005.12.038 (Pubitemid 43190229)
239. Kaeberlein M., McDonagh T., Heltweg B., Hixon J., Westman E. A., Caldwell S. D., Napper A., Curtis R., DiStefano P. S., Fields S., Bedalov A., Kennedy B. K., Substrate-specific activation of sirtuins by resveratrol. The Journal of Biological Chemistry 2005 280 17 17038 17045 2-s2.0-20444431507 10.1074/jbc.M500655200 (Pubitemid 41389166)
240. Kaeberlein M., Powers R. W. III, Sir2 and calorie restriction in yeast: a skeptical perspective. Ageing Research Reviews 2007 6 2 128 140 2-s2.0-34347354447 10.1016/j.arr.2007.04.001 (Pubitemid 47017806)
241. Kaeberlein M., Kennedy B. K., Does resveratrol activate yeast Sir2 in vivo? Aging Cell 2007 6 4 415 416 2-s2.0-34447634894 10.1111/j.1474-9726.2007. 00314.x (Pubitemid 47087045)
242. Smith D. L. Jr., Li C., Matecic M., Maqani N., Bryk M., Smith J. S., Calorie restriction effects on silencing and recombination at the yeast rDNA. Aging Cell 2009 8 6 633 642 2-s2.0-74049131893 10.1111/j.1474-9726.2009.00516.x
243. Bass T. M., Weinkove D., Houthoofd K., Gems D., Partridge L., Effects of resveratrol on lifespan in Drosophila melanogaster and Caenorhabditis elegans. Mechanisms of Ageing and Development 2007 128 10 546 552 2-s2.0-34848927457 10.1016/j.mad.2007.07.007 (Pubitemid 47498522)
244. Greer E. L., Brunet A., Different dietary restriction regimens extend lifespan by both independent and overlapping genetic pathways in C. elegans. Aging Cell 2009 8 2 113 127 2-s2.0-63549108476 10.1111/j.1474-9726.2009.00459.x
245. Kaeberlein T. L., Smith E. D., Tsuchiya M., Welton K. L., Thomas J. H., Fields S., Kennedy B. K., Kaeberlein M., Lifespan extension in Caenorhabditis elegans by complete removal of food. Aging Cell 2006 5 6 487 494 2-s2.0-33751250243 10.1111/j.1474-9726.2006.00238.x (Pubitemid 44782617)
246. Zou S., Carey J. R., Liedo P., Ingram D. K., Müller H. G., Wang J. L., Yao F., Yu B., Zhou A., The prolongevity effect of resveratrol depends on dietary composition and calorie intake in a tephritid fruit fly. Experimental Gerontology 2009 44 6-7 472 476 2-s2.0-67349196506 10.1016/j.exger.2009.02.011
247. Riesen M., Morgan A., Calorie restriction reduces rDNA recombination independently of rDNA silencing. Aging Cell 2009 8 6 624 632 2-s2.0-74049161289 10.1111/j.1474-9726.2009.00514.x
248. Pacholec M., Bleasdale J. E., Chrunyk B., Cunningham D., Flynn D., Garofalo R. S., Griffith D., Griffor M., Loulakis P., Pabst B., Qiu X., Stockman B., Thanabal V., Varghese A., Ward J., Withka J., Ahn K., SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. The Journal of Biological Chemistry 2010 285 11 8340 8351 2-s2.0-77950246109 10.1074/jbc.M109.088682
249. Baur J. A., Pearson K. J., Price N. L., Jamieson H. A., Lerin C., Kalra A., Prabhu V. V., Allard J. S., Lopez-Lluch G., Lewis K., Pistell P. J., Poosala S., Becker K. G., Boss O., Gwinn D., Wang M., Ramaswamy S., Fishbein K. W., Spencer R. G., Lakatta E. G., Le Couteur D., Shaw R. J., Navas P., Puigserver P., Ingram D. K., De Cabo R., Sinclair D. A., Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006 444 7117 337 342 2-s2.0-33751072349 10.1038/nature05354 (Pubitemid 44764104)
250. Zang M., Xu S., Maitland-Toolan K. A., Zuccollo A., Hou X., Jiang B., Wierzbicki M., Verbeuren T. J., Cohen R. A., Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes 2006 55 8 2180 2191 2-s2.0-33749349202 10.2337/db05-1188 (Pubitemid 44743614)
251. Dasgupta B., Milbrandt J., Resveratrol stimulates AMP kinase activity in neurons. Proceedings of the National Academy of Sciences of the United States of America 2007 104 17 7217 7222 2-s2.0-34249846128 10.1073/pnas.0610068104 (Pubitemid 47186035)
252. Price N. L., Gomes A. P., Ling A. J., SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metabolism 2012 15 5 675 690
253. Barger J. L., Kayo T., Vann J. M., Arias E. B., Wang J., Hacker T. A., Wang Y., Raederstorff D., Morrow J. D., Leeuwenburgh C., Allison D. B., Saupe K. W., Cartee G. D., Weindruch R., Prolla T. A., A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice. PLoS ONE 2008 3 6 2-s2.0-48349110303 10.1371/journal.pone.0002264 e2264
254. Pearson K. J., Baur J. A., Lewis K. N., Peshkin L., Price N. L., Labinskyy N., Swindell W. R., Kamara D., Minor R. K., Perez E., Jamieson H. A., Zhang Y., Dunn S. R., Sharma K., Pleshko N., Woollett L. A., Csiszar A., Ikeno Y., Le Couteur D., Elliott P. J., Becker K. G., Navas P., Ingram D. K., Wolf N. S., Ungvari Z., Sinclair D. A., de Cabo R., Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metabolism 2008 8 2 157 168 2-s2.0-48349144852 10.1016/j.cmet.2008.06.011
255. Miller R. A., Harrison D. E., Astle C. M., Baur J. A., Boyd A. R., De Cabo R., Fernandez E., Flurkey K., Javors M. A., Nelson J. F., Orihuela C. J., Pletcher S., Sharp Z. D., Sinclair D., Starnes J. W., Wilkinson J. E., Nadon N. L., Strong R., Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. The Journals of Gerontology A 2011 66 2 191 201 2-s2.0-79951794971 10.1093/gerona/glq178
256. Smith D. L. Jr., Nagy T. R., Allison D. B., Calorie restriction: what recent results suggest for the future of ageing research. European Journal of Clinical Investigation 2010 40 5 440 450 2-s2.0-77951247533 10.1111/j.1365-2362. 2010.02276.x
257. Dal-Pan A., Blanc S., Aujard F., Resveratrol suppresses body mass gain in a seasonal non-human primate model of obesity. BMC Physiology 2010 10 1, article 11 2-s2.0-77953679841 10.1186/1472-6793-10-11
258. Dal-Pan A., Terrien J., Pifferi F., Botalla R., Hardy I., Marchal J., Zahariev A., Chery I., Zizzari P., Perret M., Picq J. L., Epelbaum J., Blanc S., Aujard F., Caloric restriction or resveratrol supplementation and ageing in a non-human primate: first-year outcome of the RESTRIKAL study in Microcebus murinus. Age 2011 33 1 15 31 2-s2.0-79952537457 10.1007/s11357-010-9156-6
259. Peltz L., Gomez J., Marquez M., Resveratrol exerts dosage and duration dependent effect on human mesenchymal stem cell development. PLoS One 2012 7 5 e37162
260. Mikua-Pietrasik J., Kuczmarska A., Rubiś B., Resveratrol delays replicative senescence of human mesothelial cells via mobilization of antioxidative and DNA repair mechanisms. Free Radical Biology & Medicine 2012 52 2234 2245
261. Smoliga J. M., Baur J. A., Hausenblas H. A., Resveratrol and healtha
262. Ghanim H., Sia C. L., Abuaysheh S., Korzeniewski K., Patnaik P., Marumganti A., Chaudhuri A., Dandona P., An antiinflammatory and reactive oxygen species suppressive effects of an extract of Polygonum cuspidatum containing resveratrol. The Journal of Clinical Endocrinology & Metabolism 2010 95 9 E1 E8 2-s2.0-77956585215 10.1210/jc.2010-0482
263. Ghanim H., Abuaysheh S., Sia C. L., Korzeniewski K., Chaudhuri A., Fernandez-Real J. M., Dandona P., Increase in plasma endotoxin concentrations and the expression of toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance. Diabetes Care 2009 32 12 2281 2287 2-s2.0-72249106180 10.2337/dc09-0979
264. Ghanim H., Sia C. L., Korzeniewski K., Lohano T., Abuaysheh S., Marumganti A., Chaudhuri A., Dandona P., A resveratrol and polyphenol preparation suppresses oxidative and inflammatory stress response to a high-fat, high-carbohydrate meal. The Journal of Clinical Endocrinology & Metabolism 2011 96 5 1409 1414 2-s2.0-79955675928 10.1210/jc.2010-1812
265. Brasnyó P., Molnár G. A., Mohás M., Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. The British Journal of Nutrition 2011 106 3 383 389
266. Vislocky L. M., Fernandez M. L., Biomedical effects of grape products. Nutrition Reviews 2010 68 11 656 670 2-s2.0-77958518016 10.1111/j.1753-4887. 2010.00335.x
267. Bertelli A. A. A., Das D. K., Grapes, wines, resveratrol, and heart health. Journal of Cardiovascular Pharmacology 2009 54 6 468 476 2-s2.0-74949098826 10.1097/FJC.0b013e3181bfaff3
268. Dohadwala M. M., Vita J. A., Grapes and cardiovascular disease. The Journal of Nutrition 2009 139 9 17885 17935 2-s2.0-69549138125 10.3945/jn.109.107474
269. Leifert W. R., Abeywardena M. Y., Grape seed and red wine polyphenol extracts inhibit cellular cholesterol uptake, cell proliferation, and 5-lipoxygenase activity. Nutrition Research 2008 28 11 729 737 2-s2.0-55349089239 10.1016/j.nutres.2008.08.007
270. Wallerath T., Deckert G., Ternes T., Anderson H., Li H., Witte K., Förstermann U., Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 2002 106 13 1652 1658 2-s2.0-0037167677 10.1161/01.CIR.0000029925. 18593.5C
271. Wallerath T., Li H., Gödtel-Ambrust U., Schwarz P. M., Förstermann U., A blend of polyphenolic compounds explains the stimulatory effect of red wine on human endothelial NO synthase. Nitric Oxide 2005 12 2 97 104 2-s2.0-14644405529 10.1016/j.niox.2004.12.004 (Pubitemid 40312451)
272. Leikert J. F., Räthel T. R., Wohlfart P., Cheynier V., Vollmar A. M., Dirsch V. M., Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation 2002 106 13 1614 1617 2-s2.0-0037167653 10.1161/01.CIR.0000034445. 31543.43
273. Gresele P., Pignatelli P., Guglielmini G., Carnevale R., Mezzasoma A. M., Ghiselli A., Momi S., Violi F., Resveratrol, at concentrations attainable with moderate wine consumption, stimulates human platelet nitric oxide production. The Journal of Nutrition 2008 138 9 1602 1608 2-s2.0-51049085099
274. Kennedy D. O., Wightman E. L., Reay J. L., Lietz G., Okello E. J., Wilde A., Haskell C. F., Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation. The American Journal of Clinical Nutrition 2010 91 6 1590 1597 2-s2.0-77953032816 10.3945/ajcn.2009.28641
275. Wong R. H. X., Howe P. R. C., Buckley J. D., Coates A. M., Kunz I., Berry N. M., Acute resveratrol supplementation improves flow-mediated dilatation in overweight/obese individuals with mildly elevated blood pressure. Nutrition, Metabolism and Cardiovascular Diseases 2011 21 11 851 856 2-s2.0-77954977872 10.1016/j.numecd.2010.03.003
276. Agarwal B., Baur J. A., Resveratrol and life extension. Annals of the New York Academy of Sciences 2011 1215 1 138 143 2-s2.0-78851470225 10.1111/j.1749-6632.2010.05850.x
277. Crespo J. L., Hall M. N., Elucidating TOR signaling and rapamycin action: lessons from Saccharomyces cerevisiae. Microbiology and Molecular Biology Reviews 2002 66 4 579 591 2-s2.0-0036899644 10.1128/MMBR.66.4.579-591.2002 (Pubitemid 35425110)
278. Bjedov I., Toivonen J. M., Kerr F., Slack C., Jacobson J., Foley A., Partridge L., Mechanisms of life span extension by rapamycin in the fruit fly Drosophila melanogaster. Cell Metabolism 2010 11 1 35 46 2-s2.0-72649091698 10.1016/j.cmet.2009.11.010
279. Anisimov N., Zabezhinski M. A., Popovich I. G., Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice. Cell Cycle 2011 10 24 4230 4236 10.4161/cc.10.24.18486
280. Majumder S., Caccamo A., Medina D. X., Lifelong rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1 β and enhancing NMDA signaling. Aging Cell 2012 11 2 326 335 10.1111/j.1474-9726.2011. 00791.x
281. Payne G., Laporte A., Deber R., Coyte P. C., Counting backward to health care's future: using time-to-death modeling to identify changes in end-of-life morbidity and the impact of aging on health care expenditures. The Milbank Quarterly 2007 85 2 213 257 2-s2.0-34447257681 10.1111/j.1468-0009.2007.00485.x
282. Yazdanyar A., Newman A. B., The burden of cardiovascular disease in the elderly: morbidity, mortality, and costs. Clinics in Geriatric Medicine 2009 25 4 563 577 2-s2.0-70449753778 10.1016/j.cger.2009.07.007
283. Mesterton J., Wimo A., By Å., Langworth S., Winblad B., Jönsson L., Cross sectional observational study on the societal costs of Alzheimer's disease. Current Alzheimer Research 2010 7 4 358 367 2-s2.0-77953977259 10.2174/156720510791162430
284. Atzmon G., Schechter C., Greiner W., Davidson D., Rennert G., Barzilai N., Clinical phenotype of families with longevity. Journal of the American Geriatrics Society 2004 52 2 274 277 2-s2.0-0842296490 10.1111/j.1532-5415.2004. 52068.x (Pubitemid 38233493)
285. Atzmon G., Rincon M., Rabizadeh P., Barzilai N., Biological evidence for inheritance of exceptional longevity. Mechanisms of Ageing and Development 2005 126 2 341 345 2-s2.0-11144316145 10.1016/j.mad.2004.08.026 (Pubitemid 40038355)
286. Barzilai N., Gabriely I., Genetic studies reveal the role of the endocrine and metabolic systems in aging. The Journal of Clinical Endocrinology & Metabolism 2010 95 10 4493 4500 2-s2.0-77957759265 10.1210/jc.2010-0859
287. Haigis M. C., Yankner B. A., The aging stress response. Molecular Cell 2010 40 2 333 344 2-s2.0-78649350746 10.1016/j.molcel.2010.10.002
288. Nipič D., Pirc A., Banič B., Šuput D., Milisav I., Preapoptotic cell stress response of primary hepatocytes. Hepatology 2010 51 6 2140 2151 2-s2.0-77952715765 10.1002/hep.23598